Eliminating Medication Overload: a National Action Plan

Total Page:16

File Type:pdf, Size:1020Kb

Eliminating Medication Overload: a National Action Plan Eliminating Medication Overload: A National Action Plan JANUARY 2020 About the Lown Institute action plan The Lown Institute convened 22 experts in medication use and polypharmacy into a working group to develop Eliminating medication overload: A national action plan. From July 2018 to July 2019, the working group convened on monthly phone calls to develop this comprehensive action plan. The creation of this action plan, including research, analysis, and writing, was supported by the Gordon and Betty Moore Foundation. We are grateful to our GBMF program officers, Beth Metcalf and Julie Lawrence, without whose guidance and support this initiative would not have been possible. The Lown Institute is a nonprofit think tank advocating bold ideas for a just and caring system for health. www.lowninstitute.org. Eliminating Medication Overload: A National Action Plan Working Group on Medication Overload Judith Garber, writer Shannon Brownlee and Karen Kahn, editors The Lown Institute This work was supported by a grant from the Gordon and Betty Moore Foundation (#6954) Copyright © 2020 The Lown Institute, All Rights Reserved Suggested citation: Eliminating medication overload: A national action plan. Working Group on Medication Overload. Brookline, MA: The Lown Institute, 2020. Endorsing Organizations Geropsychiatric Nursing Collaborative International Group for Reducing Inappropropriate Medication Use & Polypharmacy (IGRIMUP) * The American Geriatrics Society (AGS) affirms the value of this document. Affirmation of value means that AGS supports the general principles in this document and believes it is of general benefit to its membership. Working group members Emily G. McDonald, MD, MSc Lown Institute project staff Assistant Professor of Medicine, Poppy Arford Shannon Brownlee, MSc, McGill University Health Centre Patient Advocate Senior Vice President Project lead and editor Cynthia Boyd, MD, MPH Joseph S. Ross, MD, MHS Professor of Medicine and of Public Health, Professor of Medicine, Vikas Saini, MD, President Johns Hopkins University Yale University Project advisor Co-Principal Investigator, U.S. Deprescribing Research Network James Rudolph, MD Judith Garber, MPP, Health Policy Professor of Medicine, Brown University and Communications Fellow Theresa Brown, BSN, RN, FAAN Writer, action plan University of Pittsburgh Nilay Shah, PhD Associate Professor of Health Services School of Nursing Julia Healey, Assistant of Programs Research, Mayo Clinic Faculty and Author and Operations Writer, issue briefs Alan Cassels Kristin Zimmerman, PharmD, Communications Director, BCACP, BCGP Carissa Fu, MSc, Director of Program Associate Professor, Therapeutics Initiative, Operations University of British Columbia Virginia Commonwealth University Project manager Megan Chock, MD, MPH Andrew Zullo, PharmD, ScM, PhD Aaron Toleos, Vice President Assistant Professor, Brown University Geriatric Medicine, Kaiser Permanente, of Communications Hawaii Communications lead Brandon Combs, MD Advisory committee members Associate Professor of Medicine, Anthony Barrueta, JD Consultants Senior Vice President, Government University of Colorado School of Medicine Karen Kahn Relations, Kaiser Permanente Editing and media relations Lynn Deguzman, PharmD, BCGP Regional Clinical Operations Manager, John Bulger, DO, MBA Nicole Caddell Kaiser Permanente, Northern California Chief Medical Officer, Geisinger Health Plan Designer, action plan and issue briefs Maisha Draves, MD, MPH John Devlin, PharmD, FCCM, FCCP Medical Director of Pharmacy, Professor of Pharmacy, The Permanente Medical Group Northeastern University Family Medicine Physician Donna Marie Fick, PhD, RN, FGSA, Gayle Banner Esposito FAAN Patient Safety Advocate, Professor and Director of the Center Mothers Against Medical Error of Geriatric Nursing Excellence, Penn State College of Nursing Helen Haskell, MA President, Mothers Against Medical Error Terry Fulmer, PhD, RN, FAAN President, the John A. Hartford Foundation Corinne M. Hohl, MD Associate Professor, Emergency Medicine, James F. Graumlich, MD University of British Columbia Governor, American College of Physicians Holly Holmes, MD, MS Leigh Purvis, MPA Division Director, Associate Professor, Director, Health Services Research, AARP Geriatric and Palliative Medicine, McGovern Medical School Gordon Schiff, MD Associate Director, Brigham and Women’s Todd C. Lee, MD, MPH Center for Patient Safety Research and Associate Professor of Medicine, Practice; Associate Professor of Medicine, McGill University Health Centre Harvard Medical School Sharon Levine, MD Michael Steinman, MD Board of Directors, School of Medicine, Professor of Medicine, Kaiser Permanente University of California, San Francisco Co-Principal Investigator, Amy Linsky, MD, MSc U.S. Deprescribing Research Network Assistant Professor of Medicine, Boston University; Physician, Johanna Trimble VA Boston Healthcare System Patient Champion, Patients for Patient Safety Canada James McCormack, BSc (Pharm), PharmD Jeff Williamson, MD, MHS Professor, Faculty of Pharmaceutical Chief of Geriatric Medicine and Professor Sciences, University of British Columbia of Internal Medicine and Epidemiology, Wake Forest School of Medicine Table of Contents 6 Introduction CATEGORY 1: 11 Implement prescription checkups CATEGORY 2: 24 Raise awareness about medication overload CATEGORY 3: 39 Improve information at the point of care CATEGORY 4: 52 Educate and train health professionals to reduce medication overload 60 CATEGORY 5: Reduce industry influence CONCLUSION: 71 What you can do now 74 Glossary, Appendices, and References Introduction Introduction Every day, 750 older people living in the United States (age 65 and older) are hospitalized due to serious side effects from one or more medications. What is medication Over the last decade, older people sought medical treatment more than 35 million times for adverse drug events (ADEs) and were hospitalized overload? 1 more than 2 million times due to ADEs. Medication overload is the use of multiple medications that pose a greater risk of harm These numbers point to an emerging threat: the epidemic of medication than benefit. There is no strict cutoff for when overload among older Americans. In a 2019 report, “Medication the number of medications becomes harmful, Overload: America’s Other Drug Problem,” the Lown Institute found that multiple medication use among older adults is widespread, growing, and but the more a person is taking, the greater their causes significant harm. More than 40 percent of older adults take five likelihood of experiencing harm, including serious, or more prescription medications a day, a 200 percent rise over the past even life-threatening adverse drug events. 20 years. When over-the-counter drugs and supplements are included, two-thirds of older Americans take five or more medications. Medication While drugs provide benefits to many people, taking multiple overload: Scope, medications (called “polypharmacy” in the scientific literature) also increases the risk of serious, even life-threatening side effects. Older harms, and people are especially vulnerable to delirium, internal bleeding, dementia, drivers and falling. Other ADEs can include strokes, heart attacks, infections, and death. For every additional medication, a person’s risk of suffering an ADE increases by 7-10 percent.2-4 Numerous forces and incentives in the U.S. health care system make it easy for clinicians to prescribe medications and difficult to scale back the dosage or deprescribe (stop a medication). Among the many drivers of medication overload, the Lown Institute’s report identified three overarching themes: 1. Both patients and clinicians are steeped in a culture of prescribing, which promotes a “pill for every ill.” Direct-to-consumer drug advertising, the increasing medicalization of normal aging, the hurried pace of medical care, and the urge among doctors and other clinicians to “do something” about medical conditions all contribute to the culture of prescribing. 2. Clinicians struggle to prescribe and deprescribe appropriately in the face of significant information and knowledge gaps. Medical education and training often lack sufficient discussion and skill building around appropriate prescribing and deprescribing. Moreover, clinical practice guidelines offer little information about how to guide prescribing for older patients with multiple chronic conditions or how to safely stop a drug.5,6 2. The U.S. has a highly fragmented health care system, which leads to individuals receiving prescriptions from many different providers in various care settings. Too often, no single clinician or team is coordinating care and keeping track of all of the medications a patient has been prescribed. 6 Eliminating Medication Overload: A National Action Plan | Lown Institute Introduction Every day, 750 older people living in the United States (age 65 and older) are hospitalized due to serious side effects from one or more medications. What is medication Over the last decade, older people sought medical treatment more than 35 million times for adverse drug events (ADEs) and were hospitalized overload? 1 more than 2 million times due to ADEs. Medication overload is the use of multiple medications that pose a greater risk of harm These numbers point to an emerging threat: the epidemic of medication than benefit. There is no strict cutoff for when overload among older Americans. In a 2019 report, “Medication the number of medications becomes harmful, Overload: America’s Other Drug
Recommended publications
  • Depression and Antidepressants in Australia and Beyond - a Critical Public Health Analysis Melissa Raven University of Wollongong
    University of Wollongong Research Online University of Wollongong Thesis Collection University of Wollongong Thesis Collections 2012 Depression and antidepressants in Australia and beyond - a critical public health analysis Melissa Raven University of Wollongong Recommended Citation Raven, Melissa, Depression and antidepressants in Australia and beyond - a critical public health analysis, Doctor of Philosophy thesis, Faculty of Arts, University of Wollongong, 2012. http://ro.uow.edu.au/theses/3686 Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library: [email protected] Depression and antidepressants in Australia and beyond A critical public health analysis A thesis submitted in fulfilment of the requirements for the award of the degree Doctor of Philosophy from UNIVERSITY OF WOLLONGONG by Melissa Raven BA(Hons), MPsych(Clin), MMedSci(ClinEpid) Faculty of Arts 2012 ii Certification I, Melissa Raven, declare that this thesis, submitted in fulfilment of the requirements for the award of Doctor of Philosophy, in the Faculty of Arts, University of Wollongong, is wholly my own work unless otherwise referenced or acknowledged. The document has not been submitted for qualifications at any other academic institution. Melissa Raven 5 July 2012 iii iv Concise table of contents List of acronyms .................................................................................... xiii Abstract ..................................................................................................
    [Show full text]
  • Polypharmacy and the Senior Citizen: the Influence of Direct-To-Consumer Advertising
    2021;69:19-25 CLINICAL GETRIATRICS - ORIGINAL INVESTIGATION doi: 10.36150/2499-6564-447 Polypharmacy and the senior citizen: the influence of direct-to-consumer advertising Linda Sperling, DHA, MSN, RN1, Martine B. Fairbanks, Ed.D, MA, BS2 1 College of nursing, University of Phoenix, Arizona, USA; 2 College of doctoral studies, University of Phoenix, Arizona, USA Background. Polypharmacy, or taking five or more medications dai- ly, can lead to poor medication compliance and an increased risk for adverse drug-to-drug interactions that may eventually lead to death. The study was designed to explore the questions of how age, the re- lationship between the physician and patient, and television, radio, magazines and modern electronic technology, such as the Internet, affect patients’ understanding of their medical care. Two main areas addressed in this research study included the pharmaceutical indus- try’s influence on consumer decisions to ask a physician for a particular medication, and the prescribing practices of the physician. Methods. This qualitative phenomenological study began with pre- screening volunteer residents in a nursing home to discover poten- tial participants who met the criteria of using five or more medicines daily. We then interviewed 24 participants who met the criteria, using semi-structured interview questions. Results. Four core themes emerged from this study: professional trust, professional knowledge, communication deficit, and direct-to-consum- Received: April 30, 2020 er advertising. Participants reported trusting their doctors and taking Accepted: November 2, 2020 medications without question, but most knew why they were taking the Correspondence medications. Participants also reported seeing ads for medications, but Linda Sperling DHA, MSN, RN only one reported asking a physician to prescribe the medication.
    [Show full text]
  • 2019 Abstract Book
    2019 NATIONAL MEETING / ÉDITION 2019 DU CONGRÈS ANNUEL: TAKING ACTION LE SURDIAGNOSTIC : PASSEZ À L’ACTION ABSTRACT BOOK CAHIER DES RÉSUMÉS Dear National Meeting Attendees, We are excited to be hosting the National Meeting in Montreal, Quebec and for the first time featuring both English and French sessions. I would like to thank our co-host, the Quebec Medical Association and our partner, the Canadian Medical Association for their contributions to this year’s event. The 2019 National Meeting includes a special celebration marking the fifth anniversary of the Choosing Wisely Canada campaign. I am thrilled to celebrate this important milestone with the Choosing Wisely Canada community and recognize our collective efforts in reducing unnecessary tests and treatments. In the past five years, Choosing Wisely Canada has evolved from a conversation between clinicians and patients to the national voice for reducing unnecessary tests and treatments in health care. There has been unparalleled engagement and dedication from clinicians, administrators, researchers and systems leaders. There are close to 350 quality improvement projects related to the campaign taking root across the country and 12 active provincial and territorial campaigns to help accelerate the pace of change locally. As Chair of Choosing Wisely Canada, I am proud of the sizable impact our community has had in Canada and the momentum the campaign has gained. This year’s theme Taking Action is reflective of our next chapter of the campaign. The abstracts featured in this book are a testament to the breadth of projects taking place from coast-to-coast and showcase the energy of our community in putting campaign recommendations into practice.
    [Show full text]
  • Overdiagnosis and Overtreatment Over Time
    University of Massachusetts Medical School eScholarship@UMMS Family Medicine and Community Health Publications and Presentations Family Medicine and Community Health 2015-6 Overdiagnosis and overtreatment over time Stephen A. Martin University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/fmch_articles Part of the Community Health and Preventive Medicine Commons, Diagnosis Commons, Family Medicine Commons, Preventive Medicine Commons, and the Primary Care Commons Repository Citation Martin SA, Podolsky SH, Greene JA. (2015). Overdiagnosis and overtreatment over time. Family Medicine and Community Health Publications and Presentations. https://doi.org/10.1515/dx-2014-0072. Retrieved from https://escholarship.umassmed.edu/fmch_articles/318 Creative Commons License This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Family Medicine and Community Health Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. Diagnosis 2015; 2(2): 105–109 Opinion Paper Open Access Stephen A. Martin*, Scott H. Podolsky and Jeremy A. Greene Overdiagnosis and overtreatment over time Abstract: Overdiagnosis and overtreatment are often Introduction thought of as relatively recent phenomena, influenced by a contemporary combination of technology, speciali- In recent years, an increasing number of clinicians, jour- zation, payment models, marketing, and supply-related nalists, health service researchers, and policy-makers demand. Yet a quick glance at the historical record reveals have drawn attention to the problems of overdiagnosis that physicians and medical manufacturers have been and the overtreatment that it so often engenders [1, 2].
    [Show full text]
  • Opioid Weaning Guidance Document Primary Care GENERAL CONSIDERATIONS: 1
    Opioid Weaning Guidance Document Primary Care GENERAL CONSIDERATIONS: 1. Determine if the goal is a dose reduction or complete discontinuation of agent(s). 2. Weans should occur gradually to minimize the risk of withdrawal symptoms. Weaning opioids may take 6 months or more depending on the total opioid dose and the individual patient’s response to the opioid wean. There is no need to rush this process as this may only cause more distress for the patient. 3. Optimize non-opioid pain management strategies. This link provides options for non-opioid strategies: https://www.cdc.gov/drugoverdose/pdf/alternative_treatments-a.pdf a. Recommend implementing one non-opioid agent at a time b. Evaluate and discontinue any agents that are ineffective c. Do not exceed maximum recommended doses or combine multiple agents from the same medication class d. Avoid use of benzodiazepines or any sedative hypnotic agents 4. Set expectations and functional goals with patient prior to initiation of the opioid wean. 5. Educate patient on the change in opioid tolerance over time during the opioid wean and risk for overdose if they resume their starting dose or a previously stable higher dose. Discuss/prescribe naloxone to minimize the risk of overdose. 6. Screen for and treat any untreated/under-treated depression. Depression may make the weaning process more challenging. MORPHINE EQUIVALENT DOSE CALCULATOR: 1. Link to calculator: http://www.agencymeddirectors.wa.gov/Calculator/DoseCalculator.htm 2. This calculator can be utilized to determine the current morphine equivalent dose your patient is receiving at baseline. If the goal is for opioid dose reduction, this calculator can also be used to determine your goal “ending” dose.
    [Show full text]
  • Qato Et Al, “Changes in Prescription and Over-The-Counter Medi
    Polypharmacy: time to get beyond numbers Invited commentary on: Qato et al, “Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011” and Jou et al, “Non-disclosure of complementary and alternative medicine (CAM) use to usual care providers: Findings from the 2012 National Health Interview Survey” Michael A. Steinman, MD Division of Geriatrics, University of California, San Francisco and the San Francisco VA Health Care System Word count: 1023 References: 7 Support: Supported by grants from the National Institute on Aging (K24-AG049057-01 and P30- AG044281) Acknowledgement / Disclosure: Dr. Steinman is a consultant for iodine.com, an internet start-up company. Corresponding author: Michael A. Steinman, MD 4150 Clement St, VA Box 181G San Francisco, CA 94121 [email protected] When I tell someone that I am a geriatrician, I often get the same response. I am told half- jokingly that the person needs my services. Then, I am regaled with a story of how the person’s older parent, grandparent, or spouse is prescribed an enormous number of medications, thinks they might be causing problems, and doesn’t know what to do about it. It is this view of polypharmacy that often dominates patients’, and increasingly clinicians’, experience of medication use. This skeptical perspective is largely justified. The number of medications a person uses is by far the strongest risk factor for medication-related problems. As the number of medications rises, adverse drug reactions become more common. Adherence worsens. Out-of-pocket costs rise.
    [Show full text]
  • Polypharmacy in the Elderly Educational Format Faculty Expertise Required Expertise in the Field of Study
    2019 AAFP FMX Needs Assessment Body System: Geriatrics Session Topic: Polypharmacy in the Elderly Educational Format Faculty Expertise Required Expertise in the field of study. Experience teaching in the field of study is desired. Preferred experience with audience Interactive REQUIRED response systems (ARS). Utilizing polling questions and Lecture engaging the learners in Q&A during the final 15 minutes of the session are required. Expertise teaching highly interactive, small group learning environments. Case-based, with experience developing and Problem- teaching case scenarios for simulation labs preferred. Other Based workshop-oriented designs may be accommodated. A typical OPTIONAL Learning PBL room is set for 50-100 participants, with 7-8 each per (PBL) round table. Please describe your interest and plan for teaching a PBL on your proposal form. Learning Objective(s) that will close Outcome Being Professional Practice Gap the gap and meet the need Measured Family physicians have 1. Use evidence-based criteria (e.g. Learners will gaps in knowledge and BEERS, STOPP, START) to submit written performance in evaluating evaluate for potentially adverse drug commitment to for potentially adverse drug events, among elderly patients change statements events, among elderly receiving multiple medications. on the session patients receiving multiple 2. Develop a systematic approach, evaluation, medications. including applicable REMS, to indicating how Family physicians have managing elderly patients with they plan to gaps in knowledge and
    [Show full text]
  • Deprescribing
    A GUIDE TO deprescribing OPIOIDS KEY POINTS CONTEXT This guide considers the use of opioid medications U Opioid therapy is not indicated for the long- in the treatment of chronic non-cancer pain. term management of chronic non-cancer pain. U Opioid treatment of chronic non-cancer RECOMMENDED pain does not seem to fulfil any of the key DEPRESCRIBING STRATEGY opioid treatment goals: pain relief, improved quality of life and improved functional Deprescribing or tapering of opioids is more likely to be successful when the person is aware of the issues with capacity. long term opioid use. U Opioids are playing a diminishing role in the A number of consumer resources are available to assist modern management of chronic pain. with management of chronic pain. A good quality Australian resource is available through the Hunter U Multidisciplinary pain management Integrated Pain Service at www.hnehealth.nsw.gov.au/ programs utilising psychology, exercise and pain/. functional-based outcomes result in better There are multiple sections written for consumers on quality of life and better pain management understanding chronic pain, and understanding five key than use of opioids. treatment areas: Biomedical, Mindbody, Connection, Activity and Nutrition. U Tolerance to the analgesic effects of opioids People with chronic non-cancer pain taking long term develops in almost all people with long term oral morphine milligram equivalent of: use. U 120mg or more daily should be considered for opioid deprescribing. This will usually include dose reduction U Long term opioid use is associated with with or without opioid rotation accompanied by serious adverse hormonal and psychological appropriate education and information.
    [Show full text]
  • Polypharmacy & Deprescribing
    Lauren W. Mazzurco, DO Polypharmacy & Eastern Virginia Medical School Deprescribing [email protected] • I have no conflicts of interest to disclose Objectives • Describe the concept and impact of polypharmacy in older adults • Review the benefits of and potential barriers to deprescribing • Describe the process of rational deprescribing and demonstrate practical strategies of application to clinical scenarios https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Chronic-Conditions/Downloads/2012Chartbook.pdf Scope of the problem • 30% of patients >65 are prescribed >5 medications • ~1 in 5 medications in older adults may be inappropriate • Single most predictor of harm is # of medications 1. QatoDM,AlexanderGC,ContiRM,JohnsonM, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867-2878. 2. RougheadEE,AndersonB,GilbertAL. Potentially inappropriate prescribing among Australian veterans and war widows/widowers. Intern Med J. 2007;37(6):402-405 3. SteinmanMA,MiaoY,BoscardinWJ,Komaiko KD, Schwartz JB. Prescribing quality in older veterans: a multifocal approach. J Gen Intern Med. 2014;29(10):1379-1386 4. BudnitzDS,LovegroveMC,ShehabN,Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365 (21):2002-2012. Quality Value = Cost http://ihpi.umich.edu/news/older-americans-don’t-get-–-or-seek-–-enough-help-doctors-pharmacists-drug-costs- poll-finds. Accessed
    [Show full text]
  • Donzelot, Anti-Sociology
    An Anti- sociology JACQUES DONZELOT What was it that brought a man, one day, to stretch out on the analyst's couch to relate the details of his life? This is in a sense the question Michel Foucault raised in Madness and Civilization. In order to solve this problem, Foucault described an historical sequence of three centuries during which time the division separating madness and normality was plotted. The results of his investigation show psychoanalysis to be situated at the outermost point of the confinement trappings without foregoing its fundamental implications: "Freud did deliver the patient from the existence of the asylum within which his 'liberators' had alienated him; but he did not deliver him from what was essential in this existence ... he created the psychoanalytical situation in which, by an inspired short-circuit, alienation becomes disalienation, but the doctor as alienating figure remains the key to psychoanalysis." Yes, one could tell his life history on the couch. But in such conditions as this, Foucault wonders, what was to be understood? Foucault's impertinent conclusion directed at psychoanalysis was to please Gilles Deleuze and Felix Guattari to such an extent that they used it as a starting point for their own book and were able to systematically demolish psychoanalysis, construct a new theory of desire and, while they were at it, sketch the evolution of mankind from its origins to the present day. Each of these three aspects has been spoken about differently. The first aspect has been overly discussed, owing, it would D&G systematically seem, to the book's satirical demolish psychoanalysis, style aimed at ridiculing construct a new theory of psychoanalysis.
    [Show full text]
  • Medicalisation and Overdiagnosis: What Society Does to Medicine Wieteke Van Dijk*, Marjan J
    http://ijhpm.com Int J Health Policy Manag 2016, 5(11), 619–622 doi 10.15171/ijhpm.2016.121 Perspective Medicalisation and Overdiagnosis: What Society Does to Medicine Wieteke van Dijk*, Marjan J. Faber, Marit A.C. Tanke, Patrick P.T. Jeurissen, Gert P. Westert Abstract The concept of overdiagnosis is a dominant topic in medical literature and discussions. In research that Article History: targets overdiagnosis, medicalisation is often presented as the societal and individual burden of unnecessary Received: 2 May 2016 medical expansion. In this way, the focus lies on the influence of medicine on society, neglecting the possible Accepted: 23 August 2016 influence of society on medicine. In this perspective, we aim to provide a novel insight into the influence of ePublished: 31 August 2016 society and the societal context on medicine, in particularly with regard to medicalisation and overdiagnosis. Keywords: Medicalisation, Overdiagnosis, Society Copyright: © 2016 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http:// creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. *Correspondence to: Citation: van Dijk W, Faber MJ, Tanke MA, Jeurissen PP, Westert GP. Medicalisation and overdiagnosis: Wieteke van Dijk what society does to medicine. Int J Health Policy Manag. 2016;5(11):619–622. doi:10.15171/ijhpm.2016.121
    [Show full text]
  • The Problem of Power in ADHD: a Scoping Review
    The Problem of Power in ADHD: A Scoping Review Abraham Joseph Student number 211190287 Supervisor’s Name: Marina Morrow Advisor’s Name: Mary Wiktorowicz Supervisor’s Signature: Date Approved: June 10, 2020 Advisor’s Signature: Date Approved: June 10, 2020 A Research Paper submitted to the Graduate Program in Health in partial fulfillment of the requirements for the degree of: Master of Arts Graduate Program in Health York University Toronto, Ontario M3J 1P3 Defend date: June 10, 2020 1 Table of Contents Table of Contents 2 Abstract 4 Introduction 5 Background 6 Research Goals 12 Theoretical Frameworks/Methodology 14 Research Paradigm 14 Scoping Review Method 17 Search Strategy 18 Inclusion and Exclusion Criteria 20 Data Extraction and Analysis 20 Findings and Discussion 21 Nature of Evidence 21 Places of Psychiatric Power 23 Patterns of Psychiatric Power 26 Problems of Psychiatric Power 38 Strengths and Limitations 55 Implications and Conclusions 57 2 Acknowledgements 59 References 60 Appendix A – Database Search Flow Chart 71 Appendix B – Scoping Review Charting Summary 72 3 Abstract Attention deficit hyperactivity disorder (ADHD) has become the most diagnosed mental health issue for children worldwide. There are substantive critiques of the psychiatric basis for the conceptualization, diagnosis, and treatment that dominate the ADHD context. ADHD discourse and practice are largely influenced by the biomedical framework of mental health and illness. The pervasive, continued acceptance of the dominant biomedical ADHD narrative is problematic in terms of addressing mental health care needs as well as illustrative of the influence and power that psychiatry wields with respect to the ADHD landscape.
    [Show full text]